Living in the endosymbiotic world of Wolbachia: a centennial review

R Kaur, JD Shropshire, KL Cross, B Leigh… - Cell host & …, 2021 - cell.com
The most widespread intracellular bacteria in the animal kingdom are maternally inherited
endosymbionts of the genus Wolbachia. Their prevalence in arthropods and nematodes …

Wolbachia: endosymbiont of onchocercid nematodes and their vectors

RRS Manoj, MS Latrofa, S Epis, D Otranto - Parasites & vectors, 2021 - Springer
Background Wolbachia is an obligate intracellular maternally transmitted, gram-negative
bacterium which forms a spectrum of endosymbiotic relationships from parasitism to …

Alternative treatment strategies to accelerate the elimination of onchocerciasis

M Boussinesq, G Fobi, AC Kuesel - International health, 2018 - academic.oup.com
The use of alternative (or complementary) treatment strategies (ATSs) ie differing from
annual community-directed treatment with ivermectin (CDTI) is required in some African foci …

The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis

F Risch, A Kazakov, S Specht, K Pfarr, PU Fischer… - Trends in …, 2024 - cell.com
Although lymphatic filariasis and onchocerciasis have been targeted for global elimination,
these helminth infections are still a major public health problem across the tropics and …

Repurposing strategies for tropical disease drug discovery

DM Klug, MH Gelb, MP Pollastri - Bioorganic & Medicinal Chemistry Letters, 2016 - Elsevier
Neglected tropical diseases (NTDs) and other diseases of the develo** world, such as
malaria, attract research investments that are disproportionately low compared to their …

Anti-Wolbachia drugs for filariasis

KL Johnston, WD Hong, JD Turner, PM O'Neill… - Trends in …, 2021 - cell.com
The mutualistic association between Wolbachia endosymbionts and their filarial nematode
hosts has been exploited as a validated drug target delivering macrofilaricidal outcomes …

Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis

MJ Taylor, TW von Geldern, L Ford… - Science translational …, 2019 - science.org
There is an urgent global need for a safe macrofilaricide drug to accelerate elimination of the
neglected tropical diseases onchocerciasis and lymphatic filariasis. From an anti-infective …

AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis

WD Hong, F Benayoud, GL Nixon… - Proceedings of the …, 2019 - National Acad Sciences
Onchocerciasis and lymphatic filariasis are two neglected tropical diseases that together
affect∼ 157 million people and inflict severe disability. Both diseases are caused by …

An automated, high-resolution phenotypic assay for adult Brugia malayi and microfilaria

U Kalwa, Y Park, MJ Kimber, S Pandey - Scientific Reports, 2024 - nature.com
Brugia malayi are thread-like parasitic worms and one of the etiological agents of Lymphatic
filariasis (LF). Existing anthelmintic drugs to treat LF are effective in reducing the larval …

Onchocerciasis drug development: from preclinical models to humans

A Ngwewondo, I Scandale, S Specht - Parasitology Research, 2021 - Springer
Twenty diseases are recognized as neglected tropical diseases (NTDs) by World Health
Assembly resolutions, including human filarial diseases. The end of NTDs is embedded …